Avanos Medical, Inc. (NYSE:AVNS) management will conduct a conference call for 3rd November 2020 at 9:00 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website avanos.com
Earnings Expectation
Avanos Medical, Inc. is reporting third quarter financial results on Tuesday 3rd November 2020, before market open.
According to analysts surveyed by Thomson Reuters, AVNS is expected to report 3Q20 income of $ 0.10 per share from revenue of $ 165.87 million.
For the full year, analysts anticipate top line of $ 689.37 million, while looking forward to income of $ 0.56 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 732.48 million ~ $ 746.43 million, where as bottomline are predicted in a range of $ 1.00 ~ $ 1.20 per share
Click Here For More Historical Outlooks Of Avanos Medical, Inc.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
